{
    "Trade/Device Name(s)": [
        "BreathID\u00ae Hp System"
    ],
    "Submitter Information": "Exalenz Bioscience Ltd.",
    "510(k) Number": "K130524",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011668"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ"
    ],
    "Summary Letter Date": "February 27, 2013",
    "Summary Letter Received Date": "February 28, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori",
        "13C Urea",
        "CO2 (carbon dioxide)"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Oridion Nasal FilterLine\u2122 (nasal cannula)"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID\u00ae Hp System"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy\u2122 (MCS\u2122)",
        "Electro-optical measurement"
    ],
    "Methodologies": [
        "Optical absorption spectroscopy",
        "Breath analysis"
    ],
    "Submission Type(s)": [
        "System",
        "Test kit",
        "Analyzer",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Exalenz BreathID\u00ae Hp System, a non-invasive breath test analyzer for H. pylori detection using molecular correlation spectroscopy",
    "Indications for Use Summary": "Aid in initial diagnosis and post-treatment monitoring of Helicobacter pylori infection in adult patients by measuring changes in exhaled CO2 ratios associated with urease production, administered by healthcare professionals under physician supervision",
    "fda_folder": "Microbiology"
}